Crossmark

Simvastatin inhibits the immunosuppressive effects of endometrial cancer-associated mesenchymal stem cells through TGF-β2/SMAD2/3 signaling and reduces tumor growth

Crossref DOI link: https://doi.org/10.1038/s41598-025-08686-9

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Kai-Hung

Chang, Yu-Hsun

Ding, Dah-Ching
Funding

Funding for this research was provided by:

Hualien Tzu Chi Hospital (TCRD 111-080)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 6 December 2024

Accepted: 23 June 2025

First Online: 1 July 2025

Declarations

:

: The authors declare no competing interests.

: The human cell derivation and experiments were approved by the Research Ethics Committee of Hualien Tzu Chi Hospital (IRB number: 109-257-A).

Document is current

Any future updates will be listed below